These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6112602)

  • 1. D-penicillamine treatment improves survival in primary biliary cirrhosis.
    Epstein O; Jain S; Lee RG; Cook DG; Boss AM; Scheuer PJ; Sherlock S
    Lancet; 1981 Jun; 1(8233):1275-7. PubMed ID: 6112602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.
    Jain S; Scheuer PJ; Samourian S; McGee JO
    Lancet; 1977 Apr; 1(8016):831-4. PubMed ID: 67338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis.
    Taal BG; Schalm SW; Ten Kate FW; Van Berge Henegouwen GP; Brandt KH
    Liver; 1983 Dec; 3(6):345-52. PubMed ID: 6366419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of penicillamine in advanced primary biliary cirrhosis.
    Dickson ER; Fleming TR; Wiesner RH; Baldus WP; Fleming CR; Ludwig J; McCall JT
    N Engl J Med; 1985 Apr; 312(16):1011-5. PubMed ID: 3885033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.
    Neuberger J; Christensen E; Portmann B; Caballeria J; Rodes J; Ranek L; Tygstrup N; Williams R
    Gut; 1985 Feb; 26(2):114-9. PubMed ID: 3881323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective trial of D-penicillamine in primary biliary cirrhosis.
    Matloff DS; Alpert E; Resnick RH; Kaplan MM
    N Engl J Med; 1982 Feb; 306(6):319-26. PubMed ID: 7033789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of histological progression in primary biliary cirrhosis.
    Locke GR; Therneau TM; Ludwig J; Dickson ER; Lindor KD
    Hepatology; 1996 Jan; 23(1):52-6. PubMed ID: 8550048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis.
    Bodenheimer HC; Schaffner F; Sternlieb I; Klion FM; Vernace S; Pezzullo J
    Hepatology; 1985; 5(6):1139-42. PubMed ID: 3905561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.
    Epstein O; De Villiers D; Jain S; Potter BJ; Thomas HC; Sherlock S
    N Engl J Med; 1979 Feb; 300(6):274-8. PubMed ID: 759879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
    Fleming CR; Ludwig J; Dickson ER
    Mayo Clin Proc; 1978 Sep; 53(9):587-93. PubMed ID: 355732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis: D-Penicillamine vs. placebo/no intervention in patients with primary biliary cirrhosis--Cochrane Hepato-Biliary Group.
    Gong Y; Klingenberg SL; Gluud C
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1535-44. PubMed ID: 17206942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of penicillamine on serum immunoglobulins and immune complex-reactive material in primary biliary cirrhosis.
    Bodenheimer HC; Charland C; Thayer WR; Schaffner F; Staples PJ
    Gastroenterology; 1985 Feb; 88(2):412-7. PubMed ID: 3880714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis.
    Wiesner RH; Grambsch PM; Lindor KD; Ludwig J; Dickson ER
    Hepatology; 1988; 8(3):668-76. PubMed ID: 3286461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.
    Deering TB; Dickson ER; Fleming CR; Geall MG; McCall JT; Baggenstoss AH
    Gastroenterology; 1977 Jun; 72(6):1208-12. PubMed ID: 870369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic copper accumulation in primary biliary cirrhosis.
    Benson GD
    Yale J Biol Med; 1979; 52(1):83-8. PubMed ID: 452626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy.
    Taal BG; Schalm SW
    Z Gastroenterol; 1985 May; 23(5):228-34. PubMed ID: 3909671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis.
    Beukers R; van Zanten RA; Schalm SW
    J Hepatol; 1992 Jan; 14(1):22-9. PubMed ID: 1737913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis and lichen planus.
    Powell FC; Rogers RS; Dickson ER
    J Am Acad Dermatol; 1983 Oct; 9(4):540-5. PubMed ID: 6355216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-penicillamine for primary biliary cirrhosis.
    James OF
    Gut; 1985 Feb; 26(2):109-13. PubMed ID: 3881322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.